-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $34 Price Target

Benzinga·11/10/2025 18:21:26
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $34 price target.